Yosef Yarden

7.7k total citations · 3 hit papers
49 papers, 4.9k citations indexed

About

Yosef Yarden is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Yosef Yarden has authored 49 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 21 papers in Oncology and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Yosef Yarden's work include HER2/EGFR in Cancer Research (11 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Lung Cancer Treatments and Mutations (6 papers). Yosef Yarden is often cited by papers focused on HER2/EGFR in Cancer Research (11 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Lung Cancer Treatments and Mutations (6 papers). Yosef Yarden collaborates with scholars based in Israel, United States and Italy. Yosef Yarden's co-authors include A. Ullrich, Julian Downward, E. L. V. Mayes, Joseph Schlessinger, Michael D. Waterfield, Nicholas F. Totty, Peter A. Stockwell, Lorena Verduci, Giovanni Blandino and Sabrina Strano and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Yosef Yarden

49 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences

1984 2.1k citations Yosef Yarden et al. profile →
ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation

2015 497 citations Gabriele D’Uva, Alla Aharonov et al. Nature Cell Biology profile →
The circRNA–microRNA code: emerging implications for cancer diagnosis and treatment

2019 332 citations Yosef Yarden et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yosef Yarden Israel	27	3.2k	1.6k	780	765	575	49	4.9k
Sue-Hwa Lin United States	43	2.8k 0.9×	1.7k 1.1×	734 0.9×	615 0.8×	499 0.9×	136	5.1k
Ayyappan K. Rajasekaran United States	37	2.9k 0.9×	1.4k 0.9×	639 0.8×	648 0.8×	431 0.7×	74	5.0k
William J. LaRochelle United States	43	2.8k 0.9×	951 0.6×	705 0.9×	522 0.7×	550 1.0×	81	4.9k
Ichiro Ota Japan	33	3.3k 1.0×	1.5k 0.9×	580 0.7×	1.5k 2.0×	298 0.5×	115	5.8k
Hrvoje Miletić Norway	40	2.5k 0.8×	1.1k 0.7×	596 0.8×	1.4k 1.9×	707 1.2×	118	5.3k
Kurt Ballmer‐Hofer Switzerland	40	3.7k 1.1×	1.5k 0.9×	375 0.5×	663 0.9×	870 1.5×	96	5.4k
Brad St. Croix United States	32	4.1k 1.3×	1.8k 1.1×	370 0.5×	1.4k 1.9×	761 1.3×	58	6.0k
Maria Rita Nicotra Italy	42	2.3k 0.7×	1.3k 0.8×	464 0.6×	577 0.8×	802 1.4×	79	4.3k
Johanna Lahdenranta United States	23	2.0k 0.6×	1.4k 0.9×	823 1.1×	618 0.8×	331 0.6×	51	3.6k
Annalisa Pession Italy	41	3.1k 1.0×	912 0.6×	425 0.5×	1.2k 1.5×	473 0.8×	144	5.8k

Countries citing papers authored by Yosef Yarden

Since Specialization

Citations

This map shows the geographic impact of Yosef Yarden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yosef Yarden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yosef Yarden more than expected).

Fields of papers citing papers by Yosef Yarden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yosef Yarden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yosef Yarden. The network helps show where Yosef Yarden may publish in the future.

Co-authorship network of co-authors of Yosef Yarden

This figure shows the co-authorship network connecting the top 25 collaborators of Yosef Yarden. A scholar is included among the top collaborators of Yosef Yarden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yosef Yarden. Yosef Yarden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Singh, Anamika, Ariel Erijman, Ashish Noronha, et al.. (2021). Engineered variants of the Ras effector protein RASSF5 (NORE1A) promote anticancer activities in lung adenocarcinoma. Journal of Biological Chemistry. 297(6). 101353–101353. 2 indexed citations

Romaniello, Donatella, Ilaria Marrocco, Nishanth Belugali Nataraj, et al.. (2020). Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase Inhibitor. Cancers. 12(9). 2394–2394. 40 indexed citations

Shenoy, Anjana, Nishanth Belugali Nataraj, Gili Perry, et al.. (2020). Proteomic patterns associated with response to breast cancer neoadjuvant treatment. Molecular Systems Biology. 16(9). e9443–e9443. 38 indexed citations

Romaniello, Donatella, Luigi Mazzeo, Maicol Mancini, et al.. (2018). A Combination of Approved Antibodies Overcomes Resistance of Lung Cancer to Osimertinib by Blocking Bypass Pathways. Clinical Cancer Research. 24(22). 5610–5621. 43 indexed citations

Marrocco, Ilaria, Donatella Romaniello, & Yosef Yarden. (2018). Cancer Immunotherapy: The Dawn of Antibody Cocktails. Methods in molecular biology. 1904. 11–51. 26 indexed citations

Arandkar, Sharathchandra, Noa Furth, Nishanth Belugali Nataraj, et al.. (2018). Altered p53 functionality in cancer-associated fibroblasts contributes to their cancer-supporting features. Proceedings of the National Academy of Sciences. 115(25). 6410–6415. 93 indexed citations

D’Uva, Gabriele, Alla Aharonov, Mattia Lauriola, et al.. (2015). ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation. Nature Cell Biology. 17(5). 627–638. 497 indexed citations breakdown →

Kedmi, Merav, Aldema Sas‐Chen, & Yosef Yarden. (2015). MicroRNAs and Growth Factors: An Alliance Propelling Tumor Progression. Journal of Clinical Medicine. 4(8). 1578–1599. 22 indexed citations

Yarden, Yosef, et al.. (2014). Basic cancer research: why it is essentiel for the future of cancer therapy. Bulletin du Cancer. 101(9). E25–E26. 2 indexed citations

10.

Maron, Ruth, et al.. (2013). Inhibition of pancreatic carcinoma by homo- and heterocombinations of antibodies against EGF-receptor and its kin HER2/ErbB-2. Proceedings of the National Academy of Sciences. 110(38). 15389–15394. 37 indexed citations

11.

Yarden, Yosef, et al.. (2013). Basic cancer research is essential for the success of personalised medicine. European Journal of Cancer. 49(12). 2619–2620. 17 indexed citations

12.

Spector, Neil L., Yosef Yarden, Bradley L. Smith, et al.. (2007). Activation of AMP-activated protein kinase by human EGF receptor 2/EGF receptor tyrosine kinase inhibitor protects cardiac cells. Proceedings of the National Academy of Sciences. 104(25). 10607–10612. 89 indexed citations

13.

Yarden, Yosef. (2002). Recycling of HER-ErbB Receptors: Rescue From Apoptosis and Targets for Immunotherapy. Defense Technical Information Center (DTIC). 1 indexed citations

14.

Schleef, Martin, Dominique Simon‐Chazottes, Andreas Lengeling, et al.. (1996). The gene encoding sarcoplasmic reticulum calcium ATPase-1 (Atp2al) maps to distal mouse Chromosome 7. Mammalian Genome. 7(10). 788–788. 3 indexed citations

15.

Blechman, Janna, Sima Lev, Jacob Barg, et al.. (1995). The fourth immunoglobulin domain of the stem cell factor receptor couples ligand binding to signal transduction. Cell. 80(1). 103–113. 142 indexed citations

16.

Brizzi, Maria Felice, et al.. (1994). Convergence of signaling by interleukin-3, granulocyte-macrophage colony-stimulating factor, and mast cell growth factor on JAK2 tyrosine kinase.. Journal of Biological Chemistry. 269(50). 31680–31684. 93 indexed citations

17.

Funasaka, Yoko, Teri G. Boulton, Melanie H. Cobb, et al.. (1992). c-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas.. Molecular Biology of the Cell. 3(2). 197–209. 145 indexed citations

18.

Peles, Elior, Robert B. Levy, Eran Or, Axel Ullrich, & Yosef Yarden. (1991). Oncogenic forms of the neu/HER2 tyrosine kinase are permanently coupled to phospholipase C gamma.. The EMBO Journal. 10(8). 2077–2086. 101 indexed citations

19.

Avivi, A., Yitzhak Zimmer, Avner Yayon, Yosef Yarden, & David Givol. (1991). Flg-2, a new member of the family of fibroblast growth factor receptors.. PubMed. 6(6). 1089–92. 49 indexed citations

20.

Yarden, Yosef & Elior Peles. (1991). Biochemical analysis of the ligand for the neu oncogenic receptor. Biochemistry. 30(14). 3543–3550. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact